ES471797A1 - Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos - Google Patents

Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos

Info

Publication number
ES471797A1
ES471797A1 ES471797A ES471797A ES471797A1 ES 471797 A1 ES471797 A1 ES 471797A1 ES 471797 A ES471797 A ES 471797A ES 471797 A ES471797 A ES 471797A ES 471797 A1 ES471797 A1 ES 471797A1
Authority
ES
Spain
Prior art keywords
salts
benzimidazolin
propanes
aryloxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471797A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES471797A1 publication Critical patent/ES471797A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)

Abstract

Procedimiento para la preparación de nuevos 1-ariloxi-2-hidroxi-3-alcohiloaminopropanos, racémicos u ópticamente activos de la fórmula general I **(Fórmula)** en donde R1 significa un átomo de hidrógeno o de halógeno, un grupo trifluorometilo o un grupo nitro, un grupo alcohilo recto o ramificado con 1 a 8 átomos de carbono, un grupo alcoxi recto o ramificado con 1 a 4 átomos de carbono, un grupo alcoxialcohilo con 2 a 8 átomos de carbono, un grupo alquenilo o alquinilo con 2 a 5 átomos de carbono, un grupo alqueniloxi o alquiniloxi con 3 a 6 átomos de carbono, un grupo cicloalcohilo o cicloalcoxi (eventualmente) puente y/o insaturado con 3 a 12 átomos de carbono, un radical con la fórmula parcial (CH2)x-A'' en donde x significa cero o un número entero de 1 a 3, y A'' significa un grupo ciano, amino, carboxamido o hidroxi.
ES471797A 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos Expired ES471797A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762644833 DE2644833A1 (de) 1976-10-05 1976-10-05 Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES471797A1 true ES471797A1 (es) 1979-02-01

Family

ID=5989679

Family Applications (16)

Application Number Title Priority Date Filing Date
ES462868A Expired ES462868A1 (es) 1976-10-05 1977-10-04 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alcohilena minopropanos, racemicos y opticmente ac- tivos.
ES471796A Expired ES471796A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471794A Expired ES471794A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471795A Expired ES471795A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471805A Expired ES471805A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471801A Expired ES471801A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471797A Expired ES471797A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471803A Expired ES471803A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471802A Expired ES471802A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos opticamente acti- vos
ES471804A Expired ES471804A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471807A Expired ES471807A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos derivados de fe-nilimidozolidinona
ES471798A Expired ES471798A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471806A Expired ES471806A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471808A Expired ES471808A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevas azetidinoles
ES471799A Expired ES471799A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471800A Expired ES471800A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos

Family Applications Before (6)

Application Number Title Priority Date Filing Date
ES462868A Expired ES462868A1 (es) 1976-10-05 1977-10-04 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alcohilena minopropanos, racemicos y opticmente ac- tivos.
ES471796A Expired ES471796A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471794A Expired ES471794A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471795A Expired ES471795A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471805A Expired ES471805A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471801A Expired ES471801A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos

Family Applications After (9)

Application Number Title Priority Date Filing Date
ES471803A Expired ES471803A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471802A Expired ES471802A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos opticamente acti- vos
ES471804A Expired ES471804A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471807A Expired ES471807A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos derivados de fe-nilimidozolidinona
ES471798A Expired ES471798A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471806A Expired ES471806A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES471808A Expired ES471808A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevas azetidinoles
ES471799A Expired ES471799A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES471800A Expired ES471800A1 (es) 1976-10-05 1978-07-17 Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos

Country Status (33)

Country Link
US (7) US4256756A (es)
JP (1) JPS5368775A (es)
AT (15) AT361908B (es)
AU (1) AU514600B2 (es)
BE (1) BE859415A (es)
BG (1) BG33153A3 (es)
CA (4) CA1101859A (es)
CS (1) CS197304B2 (es)
DD (5) DD143074A5 (es)
DE (1) DE2644833A1 (es)
DK (1) DK439077A (es)
ES (16) ES462868A1 (es)
FI (1) FI69066C (es)
FR (1) FR2394534A1 (es)
GB (3) GB1592975A (es)
GR (1) GR64229B (es)
HK (1) HK19385A (es)
HU (1) HU177173B (es)
IE (3) IE46158B1 (es)
IL (1) IL53043A (es)
LU (1) LU78240A1 (es)
MY (1) MY8500909A (es)
NL (1) NL7710840A (es)
NO (1) NO151411C (es)
NZ (1) NZ185356A (es)
PH (4) PH15763A (es)
PL (1) PL113879B1 (es)
PT (1) PT67107B (es)
SE (1) SE442400B (es)
SG (1) SG70884G (es)
SU (1) SU665801A3 (es)
YU (1) YU40484B (es)
ZA (1) ZA775905B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
DK187880A (da) * 1979-05-04 1980-11-05 Continental Pharma Fremgangsmaade til fremstilling af fenyl tylaminderivater
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4473501A (en) * 1981-05-04 1984-09-25 G. D. Searle & Co. Dihydro azino isoquinolines
US4379508A (en) * 1981-10-14 1983-04-12 Nestier Corporation Nesting tray with stacking keyed interlock
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) * 1983-07-09 1985-01-17 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
DE3807922A1 (de) * 1988-03-10 1989-09-21 Boehringer Mannheim Gmbh Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (es) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US6860524B1 (en) 1993-05-14 2005-03-01 William W. Rowley Polyolefin connectors
US6557907B2 (en) 1993-05-14 2003-05-06 William W. Rowley Polyethylene connectors
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6848719B2 (en) 2001-09-06 2005-02-01 William W. Rowley Bendable polymer-lined water heater connector
AR042132A1 (es) 2002-11-26 2005-06-08 Smithkline Beecham Corp Compuesto de 2- hidroxi -3-(2- aril - 1, 1 - dimetiletilamino) propoxifenilo, composicion farmaceutica que lo comprende y uso del mismo para prepararla
US20070117978A1 (en) * 2002-12-23 2007-05-24 Artesian Therapecutics, Inc Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
EP1833480A2 (en) * 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PL2224973T3 (pl) * 2007-11-29 2016-11-30 Środki konserwujące do kosmetyków, środków do pielęgnacji ciała i kompozycji farmaceutycznych
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284529A (es) * 1961-10-24
GB1066613A (en) * 1965-03-03 1967-04-26 Ici Ltd Naphthalene derivatives
NL145842B (nl) * 1969-11-28 1975-05-15 Teikoku Hormone Mfg Co Ltd Werkwijze voor het bereiden van 1-aryloxy 3-amino 2-propanolderivaten.
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3894030A (en) * 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3818017A (en) * 1973-01-04 1974-06-18 Janssen Pharmaceutica Nv 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) * 1973-07-18 1976-11-24 Ici Ltd Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (es) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
HU177173B (en) 1981-08-28
ATA57280A (de) 1980-10-15
ES471804A1 (es) 1979-02-01
ES471806A1 (es) 1979-02-01
GB1592976A (en) 1981-07-15
ES471798A1 (es) 1979-02-01
AT363082B (de) 1981-07-10
CA1125751A (en) 1982-06-15
AT361914B (de) 1981-04-10
PT67107A (de) 1977-11-01
US4296117A (en) 1981-10-20
ATA58080A (de) 1981-04-15
ATA679377A (de) 1980-09-15
ZA775905B (en) 1979-06-27
ATA56980A (de) 1980-09-15
CA1101859A (en) 1981-05-26
ES471807A1 (es) 1979-02-01
LU78240A1 (es) 1979-02-02
ES471801A1 (es) 1979-02-01
IE822409L (en) 1978-04-05
DD134642A5 (de) 1979-03-14
ES471808A1 (es) 1979-02-01
AT361908B (de) 1981-04-10
ES462868A1 (es) 1978-12-16
AT361911B (de) 1981-04-10
FR2394534A1 (fr) 1979-01-12
ATA57380A (de) 1980-10-15
AT362362B (de) 1981-05-11
IE46159B1 (en) 1983-03-09
NO151411C (no) 1985-04-10
ATA57480A (de) 1980-10-15
ATA57780A (de) 1980-12-15
PL201286A1 (pl) 1978-12-04
IE822410L (en) 1978-04-05
NO773384L (no) 1978-04-06
PH16053A (en) 1983-06-09
AT364828B (de) 1981-11-25
DD148052A5 (de) 1981-05-06
SE7711168L (sv) 1978-05-18
ES471799A1 (es) 1979-02-01
AT362363B (de) 1981-05-11
PH15763A (en) 1983-03-22
US4212877A (en) 1980-07-15
FR2394534B1 (es) 1982-04-30
DD148051A5 (de) 1981-05-06
MY8500909A (en) 1985-12-31
GB1592977A (en) 1981-07-15
AT361913B (de) 1981-04-10
ATA57080A (de) 1980-09-15
NZ185356A (en) 1981-05-01
YU40484B (en) 1986-02-28
ES471795A1 (es) 1979-02-01
PT67107B (de) 1980-04-07
AT362364B (de) 1981-05-11
IE46158B1 (en) 1983-03-09
ATA57980A (de) 1980-12-15
SG70884G (en) 1985-04-04
US4343800A (en) 1982-08-10
US4604468A (en) 1986-08-05
ES471794A1 (es) 1979-02-01
BG33153A3 (en) 1982-12-15
YU236977A (en) 1983-01-21
IE46158L (en) 1978-04-05
IL53043A0 (en) 1977-12-30
US4255430A (en) 1981-03-10
AT361915B (de) 1981-04-10
ES471802A1 (es) 1979-02-01
AT361912B (de) 1981-04-10
AT363080B (de) 1981-07-10
AT363079B (de) 1981-07-10
CA1126271A (en) 1982-06-22
GB1592975A (en) 1981-07-15
NO151411B (no) 1984-12-27
PH19028A (en) 1985-12-06
AT363081B (de) 1981-07-10
BE859415A (fr) 1978-04-05
DE2644833A1 (de) 1978-04-20
IL53043A (en) 1982-01-31
US4381309A (en) 1983-04-26
AU2933377A (en) 1979-04-12
DK439077A (da) 1978-04-06
JPS6210988B2 (es) 1987-03-10
ATA57880A (de) 1980-10-15
AU514600B2 (en) 1981-02-19
CS197304B2 (en) 1980-04-30
JPS5368775A (en) 1978-06-19
PL113879B1 (en) 1981-01-31
AT362365B (de) 1981-05-11
GR64229B (en) 1980-02-14
ATA56880A (de) 1980-09-15
DD148050A5 (de) 1981-05-06
SU665801A3 (ru) 1979-05-30
NL7710840A (nl) 1978-04-07
CA1127643A (en) 1982-07-13
ES471805A1 (es) 1979-02-01
FI69066B (fi) 1985-08-30
SE442400B (sv) 1985-12-23
FI772823A (fi) 1978-04-06
ES471800A1 (es) 1979-02-01
ATA57580A (de) 1980-12-15
ATA56780A (de) 1980-09-15
PH18363A (en) 1985-06-13
US4256756A (en) 1981-03-17
DD143074A5 (de) 1980-07-30
FI69066C (fi) 1985-12-10
ES471803A1 (es) 1979-02-01
ATA57680A (de) 1980-12-15
IE46160B1 (en) 1983-03-09
HK19385A (en) 1985-03-22
ATA57180A (de) 1980-09-15
ES471796A1 (es) 1979-02-01

Similar Documents

Publication Publication Date Title
ES471797A1 (es) Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 alcohilenaminopropanos, racemicos u opticamente ac- tivos
ES425084A2 (es) Procedimiento para la preparacion de aminoalcoholes.
ES462658A1 (es) Un procedimiento para la preparacion de un pentapeptido.
SE7605361L (sv) Sett att framstella nya n-substituerade fenylpiperazinderivat
ES437423A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas.
DE3269187D1 (en) Heterocyclic compounds, their preparation and use
ES454668A1 (es) Procedimiento para la preparacion de nuevas homoftalimidas.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES465561A1 (es) Procedimiento para la preparacion de nuevas aril-alcohilami-nas.
ES8705426A1 (es) Un procedimiento para la preparacion de un derivado de piperazina.
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971103